Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  02/07/2012
 
Trade Name:  Sklice
 
Generic or Proper Name (*):  ivermectin
 
Indications Studied:  Topical treatment of head lice infestations
 
Therapeutic Category:  Pediculocide, topical
 
Ages Studied:  6 months - <4 years
 
Study #:  3
 
Study Type:  Efficacy/Safety/Pharmacokinetic/Tolerability
 
Study Design:  Open Label
 
No Patients:  30
 
No Centers:  3
 
No Countries:  1
 
BPCA(B), PREA(P):  P
 
-
-